Ixaka
Vicente is the co-founder of Rexgenero and has over 30 years’ experience of investing in healthcare, real estate and other businesses in Spain and Europe. Vicente is the founder of ESTADISTA, specialising in private equity holdings in diverse sectors including healthcare and biotechnology. Since 2009 he has focused on scientific research, development and innovation in biotechnology, licensing from public institutions a large number of preclinical advanced therapies, drugs and medical devices.
This person is not in the org chart
This person is not in any offices
Ixaka
1 followers
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.